Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
CALGB 30601: A phase II study of dasatinib (D) in patients (pts) with previously treated malignant mesothelioma (MM) Proceeding/Conference:Journal of Clinical Oncology | 2010 | ||
Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance) Proceeding/Conference:Journal of Clinical Oncology | 2015 | ||
Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: Results from CALGB 80303 Proceeding/Conference:Journal of Clinical Oncology | 2011 |